Evidence map›Paper›PMID 21110119›Full record

ArticleMolecular biology reports2011

ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1/Cip1/Sdi in response to DNA damage in normal human embryonic fibroblast (HEF) cells.

Jee-In Heo, Soo-Jin Oh, Yoon-Jung Kho, Jeong-Hyeon Kim, Hong-Joon Kang, Seong-Hoon Park, Hyun-Seok Kim, Jong-Yeon Shin, Min-Ju Kim, Sung Chan Kim and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jee-In HeoDepartment of Biochemistry, College of Medicine, Hallym University, 1 Okchon-dong Chuncheon, Gangwon-do, 200-702, Republic of Korea.
Soo-Jin Oh
Yoon-Jung Kho
Jeong-Hyeon Kim
Hong-Joon Kang
Seong-Hoon Park
Hyun-Seok Kim
Jong-Yeon Shin
Min-Ju Kim
Sung Chan Kim
Jae-Bong Park
Jaebong Kim
Jae-Yong Lee
Hallym University · KRCenter for Cancer Research · USSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since anti-apoptotic effect of ERK has not been elucidated clearly in DNA-damage-induced cell death, the role of ERK was examined in normal HEF cells treated with mild DNA damage using etoposide or camptothecin. ERK was activated by DNA damage in HEF cells. PD98059 increased apoptosis and reduced DNA-damage-induced p21Waf1/Cip1/Sdi level. Depletion of p21Waf1/Cip1/Sdi induced cell death and PD98059 induced additional cell death. DNA-damage-induced increase in cytoplasmic localization and phosphorylation of threonine residues of p21Waf1/Cip1/Sdi was reversed by PD98059. Thus, the results suggest that ERK pathway mediates anti-apoptotic effects through phosphorylation and cytoplasmic localization of p21Waf1/Cip1/Sdi in response to mild DNA damage.

Indexed as

DNA DamageApoptosisBlotting, WesternCaspase 3Cell FractionationCell LineCyclin-Dependent Kinase Inhibitor p21CytoplasmExtracellular Signal-Regulated MAP KinasesFlow CytometryHumansImmunoprecipitationPhosphorylationTetrazolium SaltsThiazolesCaspase 3CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Extracellular Signal-Regulated MAP KinasesTetrazolium SaltsThiazolesthiazolyl blue

Identifiers

PMID21110119
OpenAlexW2003925008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.